Mark Sabag, Executive Vice President of International Markets Commercial at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), recently sold a substantial block of the company's ordinary shares. The ...

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

On January 29, 2025, the U.S. Court of Appeals for the Federal Circuit affirmed the grant of a preliminary injunction by the Northern District of ...

New stocks added today: Zero Candida Technologies Inc. (TSXV:ZCT), Innovotech, Inc. (TSXV: IOT), SciSparc Ltd. (Nasdaq: SPRC) ...

Ms. Naoko Shimura and Ms. Nicola Rabson nominated for appointment as new External DirectorsMr. Shinichi Tamura, Mr. Tomohiro Tohyama and Mr.

The Association for Accessible Medicines argued that a California law was trying to regulate business outside state borders.

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...

The Federal Circuit heard oral argument in Auribundo's appeal of the district court's decision in favor of plaintiff Merck, ...

Bausch Health Cos. convinced a federal court to dismiss, for now, allegations that executives misled investors about the spin-off of Bausch + Lomb, and other corporate liabilities.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

These are the kinds of stocks long-term investors will often be interested in, since they must have excellent, resilient ...

Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...